Pfizer Said to Have Team Exploring Over-the-Counter Lipitor

Pfizer Inc., the world’s biggest drugmaker, is studying whether its Lipitor cholesterol pill can be sold as an over-the-counter medicine, according to a person familiar with the discussions.

The company hasn’t determined whether the U.S. Food and Drug Administration would allow the drug to be sold without a prescription, the person said. Pfizer has assembled a team to examine the feasibility of a switch to over-the-counter sales, as well as other options for the medicine, said the person, who asked not to be named because the deliberations are private.